Concepedia

Kathleen F. Pirollo

KF

Statistics

Publications

50

Citations

5.4K

H-Index

39

Active since

1987

Affiliations

Georgetown University(Current)

Georgetown University Medical Center

Allogene Therapeutics (United States)

Uniformed Services University of the Health Sciences

National Institute of Standards and Technology

Kathleen F. Pirollo is an author at Georgetown University specializing in oncology, molecular oncology, and drug delivery.

Publications per year

1987–2022

50

Publications

50

Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li–Fraumeni syndrome

Shiv Srivastava, Zhiqiang Zou, Kathleen F. Pirollo et al. · Nature · 1990 · 1.2K citations

, , +17

Does a targeting ligand influence nanoparticle tumor localization or uptake?

Kathleen F. Pirollo, Esther H. Chang · Trends in biotechnology · 2008 · 344 citations

, , +12

Systemic tumor-targeted gene delivery by anti-transferrin receptor scFv-immunoliposomes.

Liang Xu, Chengcheng Huang, Wei‐Qun Huang et al. · PubMed · 2002 · 246 citations

, , +17

Phase I Study of a Systemically Delivered p53 Nanoparticle in Advanced Solid Tumors

Neil Senzer, John Nemunaitis, Derek Nemunaitis et al. · Molecular Therapy · 2013 · 242 citations · Full text

, , +17

Transferrin-Liposome-Mediated Systemic p53 Gene Therapy in Combination with Radiation Results in Regression of Human Head and Neck Cancer Xenografts

Liang Xu, Kathleen F. Pirollo, Wenhua Tang et al. · Human Gene Therapy · 1999 · 220 citations · Full text

, , +17

1–5 of 50